Plastic Surgery Doctors in Englewood Cliffs, NJ Accepting Medicare

4 Plastic Surgery doctors found. Showing 1 - 4

Dr. R. Gil Altman, M.D. Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 520 Sylvan Ave Ste 202, Englewood Cliffs, NJ 07632 Phone: 201-569-3334    Fax: 201-569-3321

Dr. Baldev Singh Sandhu, M,D., Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 E Palisade Ave, Englewood Cliffs, NJ 07632 Phone: 201-337-6286

Dr. Aaron Matthew Capuano, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 700 E Palisade Ave Ste 1, Englewood Cliffs, NJ 07632 Phone: 201-820-5280    Fax: 201-408-4996

Jordan Phillip Farkas, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 570 Sylvan Ave Ste 202, Englewood Cliffs, NJ 07632 Phone: 201-587-4961

News Archive

Only 3% of patients actually receive stress management counseling: Study

While stress may be a factor in 60 to 80 percent of all visits to primary care physicians, only three percent of patients actually receive stress management counseling, say researchers at Beth Israel Deaconess Medical Center.

Advancing birth triggers an early start to neuron death, mice study shows

Moving birth a day early triggers an early start to widespread neuron death, according to new research in mice published in eNeuro.

FDA sends approvable letter for Ceftobiprole as treatment of complicated skin infections

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has announced that it received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.

Baucus takes center stage as health reform deal maker

"As President Obama's effort to overhaul the health care system seems to hit one roadblock after another in Congress, he is counting on Senator Max Baucus [D-Mont.], a political shape-shifter and crafty deal maker who is not fully trusted by either party, to help him clinch his top domestic priority," the New York Times reports in a profile of the Senate Finance Committee leader.

Investigational drug focuses on slowing Alzheimer's disease progression

Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.

Read more Medical News

› Verified 8 days ago